LEADER 03470nam 2200769Ia 450 001 9910958362703321 005 20251116173538.0 010 $a0-429-16231-6 010 $a1-4822-2103-9 010 $a1-280-05226-0 010 $a0-585-46503-7 010 $a9786610052264 010 $a0-203-48444-4 024 7 $a10.1201/b15045 035 $a(CKB)1000000000255390 035 $a(EBL)181231 035 $a(OCoLC)133159570 035 $a(SSID)ssj0000108307 035 $a(PQKBManifestationID)11127637 035 $a(PQKBTitleCode)TC0000108307 035 $a(PQKBWorkID)10044699 035 $a(PQKB)10350235 035 $a(SSID)ssj0000277130 035 $a(PQKBManifestationID)11195727 035 $a(PQKBTitleCode)TC0000277130 035 $a(PQKBWorkID)10233696 035 $a(PQKB)11529950 035 $a(MiAaPQ)EBC181231 035 $a(Au-PeEL)EBL181231 035 $a(CaPaEBR)ebr10054229 035 $a(CaONFJC)MIL5226 035 $a(OCoLC)1000429995 035 $a(OCoLC)43526775 035 $a(FINmELB)ELB157176 035 $a(EXLCZ)991000000000255390 100 $a20000214d2000 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 04$aThe B?-adrenoreceptor /$fedited by A. Donny Strosberg 205 $a1st ed. 210 $aLondon ;$aNew York $cTaylor & Francis$d2000 215 $a1 online resource (189 p.) 225 1 $aTaylor & Francis series in pharmaceutical sciences 300 $aDescription based upon print version of record. 311 08$a0-7484-0804-5 320 $aIncludes bibliographical references (p. 125-166) and index. 327 $aBook Cover; Title; Contents; List of figures; List of tables; Contributors; Preface; Abbreviations used in this book; Structure and Function of the 3-Adrenoreceptor; Regulation of the 3-Adrenoreceptor Signalling Efficacy; Using Transgenic and Gene Knockout Techniques to Assess 3-Adrenoreceptor Function; 3-Adrenoreceptor Ligands and the Pharmacology of the 3-Adrenoreceptor; The Native Human 3-Adrenoreceptor; 3-Adrenoreceptor-Mediated Responses in Heart and Vessels; 3-Adrenoreceptors in Brown and White Adipocytes: Roles in Thermogenesis and Energy Balance 327 $aThe Putative '4'-Adrenoreceptor and Other Atypical -AdrenoreceptorsReferences; Index 330 $aThe Beta-3 Adrenoreceptor plays an important role in regulating human fat storage and variants of this receptor are thought to be relevant to diabetes.In addition to the major interest in obesity and diabetes expressed by the pharmaceutical industry, increasing numbers of academic groups are attracted by this general research area. This renewed interest is of course in part stimulated by available financing from industry. It also reflects the growing realisation that metabolism remains an open frontier: little is known about adipocyte sub-populations, specific markers, or endocrine functio 410 0$aTaylor & Francis series in pharmaceutical sciences. 517 3 $aBeta 3 adrenoreceptor 606 $aBeta adrenoceptors 606 $aAdrenergic beta agonists 615 0$aBeta adrenoceptors. 615 0$aAdrenergic beta agonists. 676 $a612/.01575 701 $aStrosberg$b A. D$01877094 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910958362703321 996 $aThe B?-adrenoreceptor$94489131 997 $aUNINA